Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-126370)

Filing Details

Accession Number:: 0001209191-16-126370
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-06-07 19:59:21
Reporting Period:: 2016-06-03

Filing Date:: 2016-06-07
Accepted Time:: 2016-06-07 19:59:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1394319	Tracon Pharmaceuticals Inc.	TCON	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1654970	L Ronald Shazer	C/O Tracon Pharmaceuticals, Inc. 8910 University Center Lane, Ste. 700 San Diego CA 92122	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-06-03	1,003	$7.48	335	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2015.
The Reporting Person acquired 1,338 shares under the 2015 Equity Incentive Plan on April 20, 2016.